Acceptability of a microbicide among women and their partners in a 4-country phase I trial

American Journal of Public Health
Margaret E BentleyDavid D Celentano

Abstract

We analyzed qualitative and quantitative data for 98 HIV-negative, low-risk women in Malawi, Zimbabwe, India, and Thailand who participated in a safety and acceptability study of BufferGel, a vaginal microbicide to determine the across-country acceptability of vaginal microbicides among women and their partners. Quantitative survey data were collected at 7 and 14 days after use among enrolled women, and exit interviews were conducted with women and their partners in separate focus group discussions. Acceptability was high in all sites (73% of women approved of the microbicide). Women in Africa, where HIV infection rates are highest, were virtually unanimous in their desire for such a product, suggesting that an individual's perception of being at risk for HIV will outweigh concerns about side effects, problems applying a product, or other factors, when products are shown to be efficacious. But men and women reported that use, which was kept secret from an intimate partner, would be difficult and might "break the trust" of a relationship. Acceptability research across diverse settings through all stages of microbicide research, development, and post-licensure dissemination can help maximize acceptability and use.

Associated Clinical Trials

References

Apr 1, 1990·American Journal of Public Health·Z A Stein
Jan 12, 2001·Journal of Women's Health & Gender-based Medicine·T M HammettG R Seage
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K H MayerZ Rosenberg
Feb 15, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·J van De WijgertK Nelson
Feb 28, 2001·Sexually Transmitted Infections·C CogginsC Ellertson
Jun 26, 2001·Reproductive Health Matters·C CogginsB Friedland
Jan 5, 2002·Journal of Transcultural Nursing : Official Journal of the Transcultural Nursing Society·Martha W MoonNancy S Padian
Jan 18, 2002·Journal of Urban Health : Bulletin of the New York Academy of Medicine·D L JonesN Schneiderman
May 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Polly F HarrisonJana Bowcut

❮ Previous
Next ❯

Citations

Dec 18, 2007·Sexual Health·Mary B ShortSusan L Rosenthal
Sep 6, 2008·Sexual Health·Wendy R HolmesSusan L Rosenthal
Jun 30, 2011·AIDS Care·Rewa KohliElizabeth Tolley
Jul 19, 2006·Culture, Health & Sexuality·Elizabeth E TolleyLawrence J Severy
Nov 17, 2011·Culture, Health & Sexuality·Rebecca GiguereIan McGowan
Jul 11, 2012·Culture, Health & Sexuality·Elizabeth T MontgomeryAriane van der Straten
May 23, 2008·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·Amanda E Tanner
Sep 22, 2010·AIDS Research and Human Retroviruses·Annalene M NelJoseph Romano
Apr 7, 2007·AIDS·UNKNOWN NIMH Collaborative HIV/STD Prevention Trial Group
May 13, 2006·Sexually Transmitted Diseases·Jessica A CohenMags E Beksinska
Jun 27, 2009·Sexually Transmitted Diseases·Andrea Ries ThurmanJeanna M Piper
Nov 7, 2006·AIDS·Sara J WhiteheadJordan W Tappero
Feb 28, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kathleen M MorrowLawrence Severy
Feb 6, 2009·The AAPS Journal·Lisa Cencia Rohan, Alexandra B Sassi
Apr 25, 2008·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Joanne E MantellIda Susser
Aug 16, 2008·American Journal of Public Health·Jenny A Higgins, Jennifer S Hirsch
Feb 9, 2012·The Indian Journal of Medical Research·Gita Ramjee
Nov 22, 2011·Future Medicinal Chemistry·Joanna S OlsenStephen Dewhurst
Jan 15, 2014·Global Advances in Health and Medicine : Improving Healthcare Outcomes Worldwide·Bridgette M BrawnerLoretta Sweet Jemmott
Sep 17, 2009·AIDS and Behavior·Elizabeth T MontgomeryUNKNOWN MIRA team
Dec 13, 2006·AIDS and Behavior·Mi-Suk KangAriane van der Straten
Sep 14, 2014·Current HIV/AIDS Reports·Jennifer L BrownRalph J DiClemente
Dec 1, 2005·American Journal of Public Health·Elizabeth E Tolley, Lawrence J Severy
Dec 8, 2007·Journal of Women's Health·Beth A AuslanderSusan L Rosenthal
Jul 28, 2009·Journal of Women's Health·Robert L CookSharon L Hillier
Mar 10, 2010·Journal of Women's Health·Greg GuestKathleen M Macqueen
Jun 26, 2010·Journal of Women's Health·Sarah MartinPeter H Kilmarx
Jul 8, 2014·Pharmaceutics·Toral ZaveriGregory R Ziegler
Sep 12, 2014·Pharmaceutics·Toral ZaveriJohn E Hayes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.